mounjaro patent expiration tirzepatide patent expiry Looming GLP-1 drug expirations draw generics firms ๐ง๐ผ๐ฝ-๐ฆ๐ฒ๐น๐น๐ถ๐ป๐ด ๐๐ฟ๐๐ด๐ & ๐จ๐ฝ๐ฐ๐ผ๐บ๐ถ๐ป๐ด ๐ฃ๐ฎ๐๐ฒ๐ป๐
Description
While some patients experience diarrhea, most find the opposite, with slowed gastric emptying producing slower movement throughout the digestive system
The dual mechanism provides an additional pathway that may overcome GLP-1-only resistance
The side effect profiles differ
However, human clinical trials are limited and hence, this peptide should not be regarded as a treatment for cancer
)
Most of them are tied to how the body responds to rapid weight loss
